Brief: Astrazeneca's Enhertu Approved In EU For HER2-Positive eBC
BRIEF-Astrazeneca's Enhertu Approved In EU For HER2-Positive eBC Oct 27 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA PLC - ENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC
Source text: ID:nRSa6052Aa
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)